4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-071075
Chief Financial Officer sold 39,120 shares at $22.04 ($862,205)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bodenstedt Matthias Chief Financial Officer | 2026-06-22 | Sale 10b5-1 | −39,120 | $22.04 | $862,205 | 1,115,435 | D: show line 1 in the form |
| Open-market sales · 39,120 sh · avg $22.04 · $862,205 | |||||||
Loading xslF345X06/ownership.xml…